Hydrogen boride nanosheet as well as preparation method and application thereof

Through the preparation and application of hydrogen boronide nanosheets, the treatment problems of drug-induced and noisy sensorineural deafness have been solved, and the hearing loss has been significantly alleviated through its hydrogen production and anti-inflammatory effects, providing an effective treatment method.

CN119018905APending Publication Date: 2024-11-26SHANGHAI UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411136313.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The prior art is difficult to effectively treat drug-induced and noisy sensorineural deafness, especially irreversible hearing damage caused by ototoxic drugs and noise exposure, and lacks effective protective drugs and treatment methods.

Method used

Using hydrogen boron nanosheets, prepared by solid-state mechanical peeling and organic solvent dispersion, has the simulated activities of hydrogen production capacity, catalase, superoxide dismutase and glutathione peroxidase, which can clear the inflammatory environment. free radicals reduce the secretion of proinflammatory factors, improve the secretion of anti-inflammatory factors, and protect inner ear cells.

Benefits of technology

Hydrogen boron nanosheets significantly reduce the damage to inner ear cells by oxidative stress, inhibit inflammatory response, regulate apoptosis-related genes, significantly alleviate drug-induced and noisy hearing loss, and provide an effective and safe treatment approach.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119018905A_ABST
    Figure CN119018905A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of nano-medicines, and particularly relates to a hydrogen boride nanosheet and a preparation method and application thereof.The preparation method comprises the steps that magnesium diboride serves as a raw material, after solid mechanical stripping, the magnesium diboride and cation exchange resin are jointly added into acetonitrile, the mixture is stirred to react in the inert atmosphere, and the hydrogen boride nanosheet is obtained; and centrifuging to remove the cation exchange resin and unstripped magnesium diboride, and carrying out rotary evaporation on the supernate obtained by centrifuging to obtain the hydrogen boride nanosheet. The hydrogen boride nanosheet prepared by the method disclosed by the invention can generate hydrogen, has simulated activities of catalase, superoxide dismutase and glutathione peroxidase, has a relatively strong free radical scavenging ability, and can effectively remove ROS in an inflammatory environment, so that two proinflammatory factors, namely TNF-alpha and IL-6, secreted by M1 macrophages are reduced, and the inflammatory activity of the M1 macrophages is improved. The capacity of M2 macrophages for secreting IL-10 anti-inflammatory factors is improved, and cell tests and animal tests prove that the hydrogen boride nanosheet has a good treatment effect on sensorineural deafness.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of nanomedicine, and specifically relates to a borohydride nanosheet and a preparation method and application thereof. Background Art

[0002] Sensorineural Hearing Loss (SNHL) is one of the most common hearing impairments in clinical practice. Its main pathological changes are irreversible damage to cochlear hair cells and subsequent apoptosis and degeneration of spiral ganglion and auditory nerve. In addition to congenital genetic causes, factors that lead to SNHL also include external factors such as ototoxic drugs, noise exposure, and aging. These factors usually trigger oxidative stress responses, leading to inflammatory responses and damage to auditory sensory cells, which in turn leads to decreased auditory sensitivity. These factors lead to the complex and diverse pathogenesis of SNHL, which poses a huge challenge to clinical treatment.

[0003] Among them, drug-induced hearing loss is a progressive sensorineural hearing loss caused by exposure to ototoxic drugs. Ototoxic drugs can cause multi-faceted damage to the auditory system, mainly to the cochlea, causing inner ear ischemia, hypoxia, and excessive accumulation of free radicals. At present, with the widespread use of a large number of chemotherapy drugs and antibiotics, the incidence of drug-induced hearing loss has increased year by year. Cisplatin is a representative anti-tumor drug with ototoxic side effects. The ototoxicity of cisplatin is long-term and progressive. Since the hair cells and spiral ganglion neurons in the inner ear of mammals lack the ability to proliferate and regenerate, the sensorineural hearing loss caused by cisplatin is irreversible, mainly damaging the inner ear and significantly affecting the patient's hearing. The average incidence of cisplatin-induced ototoxic damage is 62%, which can lead to bilateral progressive irreversible sensorineural hearing loss, often manifested as an increase in the threshold of the auditory brainstem response (ABR). The specific pathological manifestations are the loss of auditory hair cells, mainly outer hair cells, and degeneration of spiral ganglion neurons.

[0004] Faced with the serious status of drug-induced deafness, the discovery of effective protective drugs has become one of the focuses of hearing research in recent years. At present, ear protection strategies targeting the damage mechanism caused by ototoxic drugs mainly include antioxidant, anti-inflammatory, anti-apoptotic, autophagy regulation, and anti-ferroptosis mechanisms. Although some therapies have been verified in preclinical work, only a few have shown a certain protective effect in clinical practice. Therefore, finding a new ear protection drug and therapy that is effective, feasible, and has no side effects is of great clinical significance for the treatment of drug-induced hearing loss.

[0005] Noise-induced hearing loss (NIHL), also known as noise-induced deafness, is a progressive sensorineural hearing loss caused by exposure to harmful noise environments. Noise exposure can cause damage to the auditory system, which is specifically manifested in the following two types of hearing loss: (1) Transient hearing loss: Hearing loss caused by short-term exposure to a noisy environment, which usually recovers naturally within a few weeks after leaving the noisy environment. (2) Permanent hearing loss: Hearing loss caused by long-term or repeated exposure to a noisy environment. This type of damage cannot recover naturally after leaving the noisy environment, resulting in permanent hearing loss.

[0006] The damage of noise to the auditory organ is mainly concentrated in the cochlea, which often leads to ischemia, hypoxia and excessive accumulation of free radicals in the inner ear, which in turn causes damage to auditory sensory cells and hearing loss. In addition, noise exposure can also cause an increase in inner ear inflammatory factors, which is considered to be an important sign of noise-induced inner ear damage, promoting in-depth research on its damage mechanism. However, despite progress in the study of the mechanism of noise-induced hearing loss, there is still a lack of effective means and drugs for the treatment of noise-induced hearing loss in clinical practice. Therefore, the development of innovative methods and drugs that can prevent or treat noise-induced hearing loss has important clinical value and application prospects. Summary of the invention

[0007] In view of the problems existing in the prior art, the purpose of the present invention is to provide a borohydride nanosheet and a preparation method and application thereof. The present invention prepares for the first time a borohydride nanosheet with hydrogen production ability, and at the same time has the simulated activity of catalase, superoxide dismutase and glutathione peroxidase and super free radical scavenging ability, which can effectively remove ROS in the inflammatory environment, reduce the secretion of two pro-inflammatory factors TNF-α and IL-6 by M1 macrophages, and improve the ability of M2 macrophages to secrete IL-10 anti-inflammatory factor, and has a good therapeutic effect on sensorineural hearing loss.

[0008] Based on the above purpose, the technical solution adopted by the present invention is as follows:

[0009] In a first aspect, the present invention provides a method for preparing borohydride nanosheets, comprising the following steps:

[0010] S1: Solid-state mechanical exfoliation of magnesium boride powder in an inert atmosphere;

[0011] S2: mixing the magnesium boride powder after solid mechanical exfoliation with a cation exchange resin and an organic solvent, stirring in an inert atmosphere, removing the cation exchange resin and unexfoliated magnesium boride by centrifugation, and collecting the supernatant;

[0012] S3: The collected supernatant is subjected to rotary evaporation and drying to obtain a yellow powder, which is the borohydride nanosheet.

[0013] Preferably, the solid-state mechanical exfoliation in step S1 comprises the following steps: mixing magnesium boride powder and zirconium oxide beads in an argon atmosphere and ball milling for 4 to 6 hours; the particle size of the zirconium oxide beads is 5 to 20 mm.

[0014] Preferably, the weight ratio of magnesium boride powder to zirconium oxide beads is 1:(10-30).

[0015] Preferably, in step S2, the inert atmosphere is nitrogen or argon; the organic solvent is acetonitrile; and the centrifugal speed is 5000-8000 rpm.

[0016] Preferably, in step S3, the temperature of the rotary evaporation is 40-60° C., the rotation speed is 80-120 rpm, and the vacuum degree is 100-150 mbar.

[0017] The invention uses magnesium boride as a raw material, and after simple solid-state mechanical stripping, the stripped magnesium boride and a cation exchange resin are dispersed together in an organic solvent, and then the unstripped magnesium boride and the cation exchange resin are removed, and the boron hydride nanosheets dispersed in the organic solvent are concentrated, purified, and dried to prepare the product. The preparation process is simple and easy.

[0018] In a second aspect, the present invention provides a borohydride nanosheet prepared by the above method.

[0019] Transmission electron microscopy showed that the borohydride nanosheets prepared by the method presented a sheet-like nanostructure, and X-ray photoelectron spectroscopy analysis proved that the borohydride nanosheets prepared by the method had good purity.

[0020] In a third aspect, the present invention provides the use of the above-mentioned borohydride nanosheets in the preparation of drugs for treating sensorineural hearing loss.

[0021] The borohydride nanosheets prepared by the present invention have the ability to produce hydrogen, and the generated hydrogen has significant antioxidant, anti-inflammatory and anti-apoptotic effects. Its antioxidant effect is mainly manifested in that hydrogen can selectively neutralize strong oxidative free radicals, such as hydroxyl radicals (·OH) and peroxynitrite (ONOO-), thereby reducing the damage of oxidative stress to inner ear cells, and oxidative stress is an important pathogenic factor of sensorineural hearing loss. Hydrogen protects inner ear hair cells and spiral ganglion cells from damage by reducing the generation and accumulation of ROS. Its anti-inflammatory effect is mainly manifested in that hydrogen can inhibit the release of inflammatory mediators, such as TNF-α, IL-1β and IL-6, etc., and reduce the inflammatory response of the inner ear. The inflammatory response plays an important role in SNHL. Hydrogen reduces the damage of the inflammatory response to the auditory system by reducing the generation and release of proinflammatory factors. Its anti-apoptotic effect is mainly manifested in that hydrogen can regulate the expression of apoptosis-related genes and proteins, such as Bcl-2 and Bax, and inhibit cell apoptosis. By inhibiting the apoptosis of inner ear cells, hydrogen helps to maintain the integrity of the inner ear structure and normal function.

[0022] The borohydride nanosheets have a strong hydrogen production capacity, and also have the simulated activity of catalase, superoxide dismutase and glutathione peroxidase, and have a strong free radical scavenging ability. At the same time, they can reduce the secretion of pro-inflammatory factors such as tumor necrosis factor (TNF-α) and interleukin 6 (IL-6) by M1 macrophages, and increase the secretion of anti-inflammatory factors such as interleukin 10 (IL-10) by M2 macrophages. The present application further confirms through cell experiments and animal experiments that the borohydride nanosheets prepared by the present invention have a good therapeutic effect on sensorineural hearing loss, and provide a convenient, safe and ideal new approach for the treatment of sensorineural hearing loss.

[0023] Preferably, sensorineural hearing loss includes drug-induced hearing loss and noise-induced hearing loss.

[0024] Drug-induced hearing loss and noise-induced hearing loss are the two most common hearing impairments in clinical sensorineural hearing loss. Cell tests and animal tests have confirmed that the borohydride nanosheets prepared by the present invention have good therapeutic effects on both types of sensorineural hearing loss.

[0025] In a fourth aspect, the present invention provides a drug for treating sensorineural hearing loss, the drug comprising a component having borohydride nanosheets as a main active ingredient.

[0026] Preferably, the dosage form of the drug is an injection, and the injection dosage of the borohydride nanosheets is 20 to 60 mg / kg.

[0027] The borohydride nanosheets prepared by the present invention are prepared into injections with physiological saline as solvent, and are used for intraperitoneal injection experiments on drug-induced deafness mouse models and noise-induced deafness mouse models. The experimental results show that the borohydride nanosheets have a significant alleviating effect on these two different types of sensorineural deafness.

[0028] Compared with the prior art, the present invention has the following beneficial effects:

[0029] (1) The present invention uses magnesium diboride as a raw material and prepares borohydride nanosheets through solid-state mechanical exfoliation, organic solvent dispersion, centrifugation, concentration, and drying. The preparation process is simple and easy.

[0030] (2) The borohydride nanosheets prepared by the present invention have excellent hydrogen production performance and also have the mimetic activity of catalase, superoxide dismutase and glutathione peroxidase, and can effectively remove H2O2, hydroxyl radicals (·OH), superoxide anions (O2 - ), ABTS free radicals, and at the same time can reduce the secretion of pro-inflammatory factors such as tumor necrosis factor (TNF-α) and interleukin 6 (IL-6) by M1 macrophages, and increase the secretion of anti-inflammatory factors such as interleukin 10 (IL-10) by M2 macrophages. It has a good alleviating effect on sensorineural hearing loss such as drug-induced hearing loss and noise-induced hearing loss. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 This is a transmission electron microscope (TEM) photograph of the borohydride nanosheets prepared in Example 1;

[0032] Figure 2 X-ray photoelectron spectrum of the borohydride nanosheets prepared in Example 1;

[0033] Figure 3 The curves of the absorption peak of MB at 665 nm corresponding to aqueous solutions of borohydride nanosheets with different concentrations in Example 1 are shown;

[0034] Figure 4 This is a result diagram of the catalase (CAT) simulation activity test of the borohydride nanosheets prepared in Example 1;

[0035] Figure 5 This is a result diagram of the glutathione peroxidase (GPx) simulation activity test of the borohydride nanosheets prepared in Example 1;

[0036] Figure 6 This is a result diagram of the superoxide dismutase (SOD) simulation activity test of the borohydride nanosheets prepared in Example 1;

[0037] Figure 7This is a result diagram of the test of the ability of the borohydride nanosheets prepared in Example 1 to scavenge hydroxyl radicals (·OH);

[0038] Figure 8 This is a result diagram of the test of the ability of the borohydride nanosheets prepared in Example 1 to scavenge 2,2-azino-bis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt (ABTS) free radicals;

[0039] Fig. 9 The results of using CCK-8 detection method to detect the cytotoxicity of different concentrations of boron hydride nanosheets on mouse cochlear hair cell line (HEI-OC1);

[0040] Fig.10 This is the result of the CCK-8 assay to detect the ability of different concentrations of borohydride nanosheets to reduce the killing of hydrogen peroxide H2O2 in the mouse cochlear hair cell line (HEI-OC1);

[0041] Fig.11 This is a graph showing the results of the CCK-8 assay to detect the ability of different concentrations of borohydride nanosheets to reduce cisplatin-induced killing of mouse cochlear hair cell lines (HEI-OC1);

[0042] Fig.12 This is the result of detecting the effect of borohydride nanosheets on the secretion of tumor necrosis factor (TNF-α) in mouse mononuclear macrophages (RAW264.7) using enzyme-linked immunosorbent assay (ELISA);

[0043] Fig.13 This is the result of detecting the effect of borohydride nanosheets on the secretion of interleukin 6 (IL-6) in mouse mononuclear macrophages (RAW264.7) using enzyme-linked immunosorbent assay (ELISA);

[0044] Fig.14 This is the result of detecting the effect of borohydride nanosheets on the secretion of interleukin 10 (IL-10) in mouse mononuclear macrophages (RAW264.7) using enzyme-linked immunosorbent assay (ELISA);

[0045] Fig.15 This is a diagram showing the results of borohydride nanosheets treating a cisplatin-induced drug-induced deafness mouse model;

[0046] Fig.16 A diagram showing the results of using borohydride nanosheets to treat noise-induced permanent noise-induced deafness in a mouse model. DETAILED DESCRIPTION

[0047] In order to better illustrate the purpose, technical scheme and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments. It should be understood by those skilled in the art that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention. The test methods used in the examples are conventional methods unless otherwise specified; the materials, reagents, etc. used can be obtained from commercial sources unless otherwise specified.

[0048] Example 1

[0049] This embodiment provides a borohydride nanosheet, and the preparation method of the nanosheet comprises the following steps:

[0050] S1: Solid-state mechanical exfoliation of MgB2 was performed under argon atmosphere using a high energy ball mill (HEBM, SPEX Sample Prep, 8000M Mixer / mill). The process was performed in a zirconium oxide (ZrO2) bottle using ZrO2 beads with a diameter of 10 mm. The specific steps are as follows:

[0051] In an argon glove box (≤0.1ppm O2 and H2O), 10g of MgB2 powder (99%; Sigma-Aldrich, St.Louis, MO, USA) and 250g of ZrO2 beads (10mm) were weighed and added to a grinding bottle with a bead-to-powder weight ratio of 25:1. The grinding bottle was sealed in an argon glove box and then ball milled for 4 hours. The ground powder was collected in the glove box and stored in the grinding bottle.

[0052] S2: 500 mg of ground magnesium diboride powder (MgB2) and 30 mL of cation exchange resin (AmberliteIR120B hydrogen; Organo Corp., Tokyo, Japan) were mixed, and 120 mL of acetonitrile (99.5%, JIS special grade; Wako, Osaka, Japan) was added, and stirred at room temperature under N2 atmosphere. After stirring for 3 days, the remaining resin and unpeeled MgB2 were removed from the solution by centrifugation (8000 rpm), and the filtrate was collected. The obtained filtrate was a yellow dispersion. The filtrate was placed in a rotary bottle using a rotary evaporator and rotary evaporated under vacuum. The rotary evaporation temperature was 40-60°C, the rotation speed was 80-120 rpm, and the vacuum degree was 100-150 mbar. The solvents such as acetonitrile were evaporated by rotary evaporation, thereby achieving the purpose of sample concentration and purification. The yellow powder finally obtained was hydrogen borate (HB) nanosheets.

[0053] The borohydride nanosheets prepared in this example were characterized by TEM. Figure 1 As shown, it can be seen that the borohydride nanosheets prepared in this embodiment are sheet-like nanostructures.

[0054] The borohydride nanosheets prepared in this example were characterized by XPS, and the spectrum thereof is as follows: Figure 2 As shown, it can be seen that borohydride nanosheets are successfully prepared by the method of this embodiment and have good purity.

[0055] The following properties of the borohydride nanosheets prepared in this example were further studied:

[0056] 1. Hydrogen generation performance test

[0057] Methylene blue (MB) can be reduced to colorless Leucomethylene Blue (LMB) in the presence of hydrogen. When platinum (Pt) is added as a catalyst to detect hydrogen, the reaction rate and sensitivity of methylene blue (MB) with hydrogen (H2) can be significantly improved. This method uses the excellent catalytic properties of platinum to accelerate the reaction process of hydrogen reducing methylene blue.

[0058] Take 2mL of MB (final concentration of 5μg / mL), add Pt (final concentration of 1μg / mL), and then add HB (final concentrations of 0, 10, 20, 40, 80μg / mL), and use a UV-visible spectrophotometer to record the changes in the absorption peak of the solution at 665nm. The results are as follows: Figure 3 As shown, with the increase of the concentration of borohydride nanosheets, the ultraviolet absorption peak of MB gradually decreases, indicating that borohydride nanosheets can produce hydrogen in a concentration-dependent manner.

[0059] 2. In vitro catalase (CAT enzyme) activity assay

[0060] CAT enzyme activity refers to the ability of CAT enzyme to catalyze the decomposition of hydrogen peroxide (H2O2) into water and oxygen. It can be detected by ultraviolet-visible absorption spectroscopy. The detection principle is as follows:

[0061] Titanium sulfate spectrophotometry (TSS): TTS is a classic colorimetric method for detecting H2O2. Titanium sulfate reacts with H2O2 to form a titanium peroxide composite precipitate, which can be dissolved in a strong acid solution, and has a characteristic absorption peak at 410nm. The concentration of the product can be directly determined by the color. And it has a linear relationship with H2O2 within a certain concentration range, and the absorbance can be measured by a UV-visible spectrophotometer. Hydrogen peroxide reacts with titanium sulfate to form a yellow compound (titanium peroxide, TiO2). This reaction qualitatively and quantitatively detects the presence of hydrogen peroxide by color change. First, prepare the H2O2 detection working solution according to 1.25g Ti(SO4)2, 8mL H2SO4, and 100mL deionized water. Add 20μL of H2O2 (10mM) to 1.2mL H2O2 detection working solution, then add different concentrations of HB aqueous solution to 2mL, react for 1h, and use a UV-visible spectrophotometer to record the changes in the absorption peak of the yellow compound at 410nm, such as Figure 4 As shown in a, with the increase of the concentration of borohydride nanosheets, the ultraviolet absorption peak of the yellow complex gradually decreases, which proves that H2O2 is removed.

[0062] Different concentrations of hydrogen peroxide were added to the aqueous solution of boron hydride nanosheets to detect the generation of oxygen. The results are as follows: Figure 4 As shown in b, with the increase of H2O2 concentration (0mM, 20mM, 40mM, 80mM, 100mM), the dissolved oxygen meter detected an increase in the oxygen content in the HB aqueous solution within 60S.

[0063] The above results indicate that HB nanosheets have catalase mimetic activity.

[0064] 3. In vitro glutathione peroxidase (GPx) activity assay

[0065] The GPx enzyme activity of borohydride nanosheets was determined using a glutathione peroxidase colorimetric kit. The determination principle is as follows: Glutathione peroxidase can remove peroxides in living cells and plays a key role in protecting cells from free radical damage. Lipids in cells easily react with free radicals to produce lipid peroxides. Glutathione peroxidase can use reduced glutathione (GSH) to reduce lipid peroxides, thereby eliminating the toxic effects of free radicals.

[0066] Glutathione peroxidase can catalyze the reaction of peroxide and reduced glutathione (GSH) to generate water and oxidized glutathione (GSSG). The remaining GSH reacts with dithiobis-dinitrobenzoic acid (DTNB) to generate yellow thionitrobenzoic acid anion (TNB). The level of yellow TNB produced by the reaction of residual GSH and DTNB was tested at 412nm. At this time, the level of glutathione peroxidase activity determines the amount of remaining GSH, thereby determining the amount of yellow TNB formed. Therefore, the amount of TNB formed is negatively correlated with the activity of glutathione peroxidase. The results are as follows: Figure 5 As shown, with the increase of the concentration of borohydride nanosheets, the difference between the sample and the blank control becomes larger, indicating that the activity of glutathione peroxidase in the sample gradually increases, indicating that borohydride nanosheets have GPx enzyme activity.

[0067] 4. In vitro SOD enzyme activity assay

[0068] The total SOD activity detection kit (NBT method) was used to determine the SOD enzyme activity of borohydride nanosheets. The kit uses the classic nitro blue tetrazolium (NBT) colorimetric method to generate superoxide anions (O2 - ), reducing nitroblue tetrazolium to blue formazan, which has strong absorption at 560nm. SOD can remove superoxide anions, thereby inhibiting the formation of formazan. The darker the blue color of the reaction solution, the lower the activity of superoxide dismutase, and vice versa. Based on this, O2 - Clearance rate.

[0069] The results are as follows Figure 6 As shown in Figure 2, with the increase of the concentration of borohydride nanosheets, superoxide anions (O2 - ), indicating that borohydride nanosheets have SOD enzyme activity and can remove superoxide anions (O2 - ).

[0070] 5. Determination of the ability to scavenge hydroxyl radicals (·OH) in vitro

[0071] The hydroxyl radical scavenging capacity colorimetric test kit was used for determination. The determination principle is H2O2 / Fe 2+ ·OH is produced through the Fenton reaction. Salicylic acid can effectively capture the produced hydroxyl free radicals and react with them to generate a colored substance 2,3-dihydroxybenzoic acid with a characteristic absorption peak at 510nm. After adding a substance with scavenging ability, the colored substance decreases, and the ability to scavenge ·OH can be judged based on the numerical change of the absorbance value at 510nm.

[0072] The results are as follows Figure 7 As shown, with the increase of borohydride nanosheet concentration, the ·OH scavenging rate increased, indicating that borohydride nanosheets can scavenge hydroxyl radicals in a concentration-dependent manner.

[0073] 6. Determination of the ability to scavenge ABTS free radicals in vitro

[0074] ABTS (2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)) free radical scavenging assay is a commonly used method for determining antioxidant capacity. This method is based on the ABTS free radical (ABTS·+) generated by the reaction of ABTS and potassium persulfate, and evaluates the antioxidant capacity by measuring the scavenging effect of antioxidants on ABTS free radicals. The specific steps are as follows:

[0075] 0.2 mL ABTS solution (7.4 mmol / L) and 0.2 mL potassium persulfate solution (2.6 mmol / L) were mixed and reacted in the dark for 24 h to generate ABTS·+, which was diluted with PBS buffer. 1.8 mL aqueous boron hydride nanosheets with different concentrations and 0.20 mL ABTS·+ solution were mixed and reacted, and then the absorption peak at 734 nm was measured by UV-visible spectroscopy. The results are as follows: Figure 8 As shown, the total antioxidant capacity increased with the increase of borohydride nanosheet concentration, indicating that it can scavenge ABTS free radicals.

[0076] 7. Biocompatibility test of borohydride nanosheets with different concentrations

[0077] The cytotoxicity of different concentrations of borohydride nanosheets was evaluated by CCK-8 method. Mouse cochlear hair cell line (HEI-OC1) was seeded in 96-well plates and cultured overnight. The culture medium was removed, and fresh DMEM culture medium containing different concentrations of borohydride nanosheets (0, 6.25, 12.5, 25, 50, 100, 200, 400, 800 μg / mL) was added to the 96-well plate and incubated with HEI-OC1 cells for 24 hours. After reaching the set time point, the cells were incubated with CCK-8 solution for 30 minutes, and then the absorbance at 450 nm was measured by microplate reader to evaluate cell viability.

[0078] The results are as follows Fig. 9 As shown, after incubating HEI-OC1 cells with borohydride nanosheets of different concentrations for 24 hours, the cell activity was always maintained at a high level, indicating that the toxicity of the borohydride nanosheets of the present invention to cells is negligible, and the borohydride nanosheets show good biocompatibility within the experimental concentration range.

[0079] 8. Protective effect of different concentrations of borohydride nanosheets on cells

[0080] In order to evaluate the ability of hydrogen boride nanosheets to reduce the killing of mouse cochlear hair cell line (HEI-OC1) by H2O2 using the CCK-8 method, the experimental method is as follows: the mouse cochlear hair cell line (HEI-OC1) was inoculated in a 96-well plate and cultured overnight, and then the culture medium was replaced with fresh DMEM culture medium containing different concentrations of hydrogen boride nanosheets (0, 12.5, 25, 50, 100, 200 μg / mL) and H2O2 (1.0 mM) and added to the 96-well plate and incubated with HEI-OC1 cells for another 6 hours; after reaching the set time, the cells were incubated with CCK-8 solution for 30 minutes, and then the absorbance at 450 nm was detected using a microplate reader to evaluate cell viability.

[0081] Alternatively, DMEM medium containing different concentrations of borohydride nanosheets (00, 12.5, 25, 50, 100, 200 μg / mL) and cisplatin (200 μM) was added to a 96-well plate and incubated with HEI-OC1 cells for another 24 h. After reaching the set time, the cells were incubated with CCK-8 solution for 30 min, and then the absorbance at 450 nm was measured using a microplate reader to assess cell viability.

[0082] The results are as follows Fig.10 and Fig.11 As shown, with the increase of the concentration of borohydride nanosheets, the activity of HEI-OC1 cells gradually increased, weakening the killing ability of H2O2 (1.0 mM) and cisplatin (200 μM) on HEI-OC1 cells.

[0083] 9. Detection of the effect of borohydride nanosheets on the secretion of TNF-α and IL-6

[0084] The effect of borohydride nanosheets on the secretion of TNF-α and IL-6 in M1 RAW264.7 cells was detected by enzyme-linked immunosorbent assay. The experimental method was as follows: RAW264.7 cells were inoculated in a 96-well plate and cultured overnight. The adherent cells were randomly divided into 4 groups, and the cells were incubated for 12 hours using different treatment culture media. The cell culture supernatant was then collected, and the concentrations of the two pro-inflammatory factors were detected using a commercially available TNF-α detection kit and an IL-6 detection kit (the specific operation method follows the manufacturer's instructions). Among them, the differences between the 4 different treatment methods are as follows:

[0085] Control group (Control): The experimental solution used was DMEM medium;

[0086] Material group (HB): The experimental solution used was DMEM medium containing 200 μg / mL HB;

[0087] Inflammation-induced group (LPS): The experimental solution used was DMEM culture medium containing lipopolysaccharide (LPS) at a concentration of 1 μg / mL.

[0088] Treatment group (LPS+HB): The experimental solution used was DMEM culture medium containing 1 μg / mL lipopolysaccharide and borohydride nanosheets (200 μg / mL).

[0089] The results are as follows Fig.12 and 13 As shown, compared with the induced inflammation group (LPS), the treatment group (LPS+HB) reduced the secretion of two pro-inflammatory factors, TNF-α and IL-6, in RAW264.7.

[0090] 10. Detection of the effect of borohydride nanosheets on the secretion of IL-10

[0091] The effect of borohydride nanosheets on the secretion of IL-10 in RAW264.7 cells was detected by enzyme-linked immunosorbent assay. The experimental method was as follows: RAW264.7 cells were inoculated in a 96-well plate and cultured overnight. The adherent cells were randomly divided into 4 groups and incubated with different treatment medium for 12 hours. The cell culture supernatant was then collected, and the concentration of the anti-inflammatory factor IL-10 was detected using a commercially available IL-10 detection kit (the specific operation method follows the manufacturer's instructions). Among them, the 4 different treatment methods are as follows:

[0092] Control group: The experimental solution used was DMEM culture medium.

[0093] Material group (HB): The experimental solution used was DMEM medium containing 200 μg / mL HB;

[0094] Inflammation-induced group (LPS): The experimental solution used was DMEM culture medium containing lipopolysaccharide at a concentration of 1 μg / mL.

[0095] Treatment group (LPS+HB): The experimental solution used was DMEM culture medium containing 1 μg / mL lipopolysaccharide and boron hydride nanosheets (200 μg / mL).

[0096] The results are as follows Fig.14 As shown, the treatment group increased the secretion of IL-10 anti-inflammatory factor in RAW264.7 compared with the induced inflammation group.

[0097] 11. Evaluation of the efficacy of borohydride nanosheets on cisplatin-induced drug-induced deafness in mice

[0098] Detecting the auditory brainstem response (ABR) of mice is a commonly used physiological measurement method to evaluate the hearing function of mice. The ABR test can determine the hearing threshold of mice to sounds of different frequencies and intensities. By recording the electrophysiological response of the auditory system to sound stimulation, researchers can understand whether mice have hearing loss and its extent. In the study of cisplatin ototoxic drugs, ABR testing is used to evaluate the effects of drugs on the hearing of mice. Detecting ABR changes at different time points after cisplatin exposure can reveal the mechanism of drug-induced hearing damage and the effects of protective treatments such as antioxidants.

[0099] Six 6-week-old male C57BL / 6 mice were randomly divided into two groups, each with three mice, after hearing tests proved that all mice had normal hearing (PreABR), including a cisplatin-induced drug-induced deafness group and a cisplatin-induced drug-induced deafness group treated with boron hydride nanosheets (30 mg / kg). The different treatments of the two groups of mice are as follows:

[0100] Cisplatin-induced drug-induced deafness group (CP): 20 mg / kg cisplatin was injected intraperitoneally into mice.

[0101] Drug treatment group (CP+HB): The mice were first intraperitoneally injected with 20 mg / kg of cisplatin, and then injected with an aqueous solution of borohydride nanosheets with physiological saline as the solvent. The injection dose of borohydride nanosheets was 30 mg / kg.

[0102] Two days later, the ABR of mice treated with different methods was tested. Fig.15 As shown, compared with the cisplatin-induced drug-induced deafness group, borohydride nanosheets significantly alleviated cisplatin-induced drug-induced deafness in mice.

[0103] 12. Evaluation of the efficacy of borohydride nanosheets on noise-induced hearing loss in mice

[0104] Six 6-week-old male C57BL / 6 mice were tested for hearing, and after confirming that all mice had normal hearing (PreABR), they were randomly divided into two groups, each with three mice, including a noise-induced noise-induced deafness group and a noise-induced deafness group treated with borohydride nanosheets (30 mg / kg). The different treatments of the two groups of mice are as follows:

[0105] Noise-induced noise-deafness group: Mice were exposed to noise (114k) for 2 h.

[0106] Drug treatment group: The mice were first exposed to 114 dB noise for 2 hours, and then injected with an aqueous solution of borohydride nanosheets with saline as the solvent. The injection dose of borohydride nanosheets was 30 mg / kg.

[0107] During this period, the auditory brainstem response (ABR) of mice was tested by detecting the mouse ABR. It is a commonly used physiological measurement method to evaluate the hearing function of mice. The ABR test can determine the hearing threshold of mice to sounds of different frequencies and intensities. By recording the electrophysiological response of the auditory system to sound stimulation, researchers can understand whether mice have hearing loss and its extent. In the noise exposure model, the ABR test is used to evaluate the hearing changes of mice before and after noise exposure. By measuring the hearing changes of mice before and after noise exposure, the damage of noise to the auditory system and the effects of protective treatments such as antioxidants are studied.

[0108] The results are as follows Fig.16 As shown, compared with the noise-induced noise-induced hearing loss group, the borohydride nanosheets significantly alleviated the noise-induced hearing loss group.

[0109] The above results show that borohydride nanosheets have excellent therapeutic effects in the treatment of sensorineural hearing loss and are a convenient, safe and ideal drug for the treatment of sensorineural hearing loss.

Claims

1. A method for preparing borohydride nanosheets, It is characterized in that The steps include: S1: Solid-state mechanical exfoliation of magnesium boride powder in an inert atmosphere; S2: mixing the magnesium boride powder after solid mechanical exfoliation with a cation exchange resin and an organic solvent, stirring in an inert atmosphere, removing the cation exchange resin and unexfoliated magnesium boride by centrifugation, and collecting the supernatant; S3: The collected supernatant is subjected to rotary evaporation and drying to obtain a yellow powder, which is the borohydride nanosheet.

2. The method for preparing borohydride nanosheets according to claim 1, It is characterized in that The solid-state mechanical exfoliation in step S1 comprises the following steps: mixing magnesium boride powder and zirconium oxide beads in an argon atmosphere and ball milling for 4 to 6 hours; the particle size of the zirconium oxide beads is 5 to 20 mm.

3. The method for preparing borohydride nanosheets according to claim 2, It is characterized in that The weight ratio of the magnesium boride powder to the zirconium oxide beads is 1:(10-30).

4. The method for preparing borohydride nanosheets according to claim 1, It is characterized in that In step S2, the inert atmosphere is nitrogen or argon; the organic solvent is acetonitrile; and the centrifugal speed is 5000-8000 rpm.

5. The method for preparing borohydride nanosheets according to claim 1, It is characterized in that The temperature of the rotary evaporation in step S3 is 40-60° C., the rotation speed is 80-120 rpm, and the vacuum degree is 100-150 mbar.

6. A borohydride nanosheet, It is characterized in that The borohydride nanosheets are prepared by the preparation method according to any one of claims 1 to 5.

7. Use of the borohydride nanosheets according to claim 6 in the preparation of drugs for treating sensorineural deafness.

8. The use according to claim 7, It is characterized in that The sensorineural hearing loss includes drug-induced hearing loss and noise-induced hearing loss.

9. A drug for treating sensorineural hearing loss, It is characterized in that The medicine comprises components with borohydride nanosheets as main active ingredients.

10. The drug for treating sensorineural deafness according to claim 9, It is characterized in that The dosage form of the drug is injection, and the injection dosage of the borohydride nanosheets is 20-60 mg / kg.

Citation Information

Cited By

  • Boron hydride / magnesium composite sheet as well as preparation method and application thereof

    CN121732234A